SARS-CoV-2 Humanized Spike Glycoprotein (S) Expression Lentivector

Streamline your COVID-19 studies with constructs expressing a humanized SARS-CoV-2 Spike Glycoprotein (S) - based on SBI's robust lentivector technology.
  • Leverage SBI's robust lentivector expression technology to study a humanized SARS-CoV-2 Spike Glycoprotein
  • Choose ready-to-package plasmid or ready-to-transduce virus
  • Additional SARS-CoV-2 expression constructs also available

Products

Catalog Number Description Size Price Quantity Add to Cart
CVD19-135PA-1 SARS-CoV-2 Spike Glycoprotein (S) Expression Lentivector, pCDH-CMV-SARS-CoV-2-hS-EF1α-Puro Plasmid 10 µg $699.00
- +
Contact Us
CVD19-135VA-1 SARS-CoV-2 Spike Glycoprotein (S) Expression Lentivector, pCDH-CMV-SARS-CoV-2-hS-EF1α-Puro Pre-packaged Lentivirus >2 x 10^6 IFUs $699.00
- +
Contact Us

Overview

Overview

Advance your COVID-19 studies with SBI SBI is helping scientists around the globe respond to the ongoing COVID-19 pandemic with research tools that get your studies up and running quickly and efficiently. Our SARS-CoV-2 Humanized Spike Glycoprotein (S) Expression Lentivector is based on our robust pCDH-CMV-MCS-EF1α-Puro Cloning and Expression Lentivector (Cat.# CD510B-1/VA-1), and delivers expression of the human codon optimized SARS-CoV-2 S protein from the CMV promoter with a separate EF1α promoter driving the expression of the puromycin resistance gene for selection. Available in both plasmid and pre-packaged lentivirus formats, the SARS-CoV-2 Humanized Spike Glycoprotein (S) Expression Lentivector enables a wide range of studies using the systems of your choice.
  • Leverage SBI's robust lentivector expression technology to study a humanized SARS-CoV-2 Spike Glycoprotein
  • Choose ready-to-package plasmid or ready-to-transduce virus
  • Additional SARS-CoV-2 expression constructs also available
  See all of our COVID-19-related Expression Constructs
Catalog NumberProduct name
CVD19-140PA/VA-1ACE2 Expression Lentivector, pCDH-CMV-ACE2-EF1α-Puro (Plasmid or Pre-packaged Lentivirus)
CVD19-100PA/VA-1NRP1 Expression Lentivector, pCDH-CMV-NRP1-EF1α-Neo (Plasmid or Pre-packaged Lentivirus)
CVD19-120PA/VA-1SARS-CoV-2 Nucleocapsid (N protein) Expression Lentivector, pCDH-CMV-SARS-CoV-2-N-EF1α-Puro (Plasmid or Pre-packaged Lentivirus)
CVD19-130PA/VA-1SARS-CoV-2 Spike Glycoprotein (S) Expression Lentivector, pCDH-CMV-SARS-CoV-2-S-EF1α-Puro (Plasmid or Pre-packaged Lentivirus)
CVD19-135PA/VA-1SARS-CoV-2 Humanized Spike Glycoprotein (S) Expression Lentivector, pCDH-CMV-SARS-CoV-2-hS-EF1α-Puro (Plasmid or Pre-packaged Lentivirus)
CVD19-200A-1HEK293 ACE2 Stable Cell Line
CVD19-260A-1HEK293-ACE2-NRP1 Overexpression Stable Cell Line
CVD19-220A-1HEK293 "N" SARS-CoV-2 Nucleocapsid Overexpression Stable Cell Line
CVD19-420A-1
CVD19-425A-1
"N" SARS-CoV-2 Nucleocapsid mRNA
CVD19-430A-1
CVD19-435A-1
"S" SARS-CoV-2 Spike Glycoprotein mRNA
 

How It Works

Supporting Data

Resources

Citations

SARS-CoV-2 Humanized Spike Glycoprotein (S) Expression Lentivector $699.00

Products

Catalog Number Description Size Price Quantity Add to Cart
CVD19-135PA-1 SARS-CoV-2 Spike Glycoprotein (S) Expression Lentivector, pCDH-CMV-SARS-CoV-2-hS-EF1α-Puro Plasmid 10 µg $699.00
- +
Contact Us
CVD19-135VA-1 SARS-CoV-2 Spike Glycoprotein (S) Expression Lentivector, pCDH-CMV-SARS-CoV-2-hS-EF1α-Puro Pre-packaged Lentivirus >2 x 10^6 IFUs $699.00
- +
Contact Us

Overview

Overview

Advance your COVID-19 studies with SBI SBI is helping scientists around the globe respond to the ongoing COVID-19 pandemic with research tools that get your studies up and running quickly and efficiently. Our SARS-CoV-2 Humanized Spike Glycoprotein (S) Expression Lentivector is based on our robust pCDH-CMV-MCS-EF1α-Puro Cloning and Expression Lentivector (Cat.# CD510B-1/VA-1), and delivers expression of the human codon optimized SARS-CoV-2 S protein from the CMV promoter with a separate EF1α promoter driving the expression of the puromycin resistance gene for selection. Available in both plasmid and pre-packaged lentivirus formats, the SARS-CoV-2 Humanized Spike Glycoprotein (S) Expression Lentivector enables a wide range of studies using the systems of your choice.
  • Leverage SBI's robust lentivector expression technology to study a humanized SARS-CoV-2 Spike Glycoprotein
  • Choose ready-to-package plasmid or ready-to-transduce virus
  • Additional SARS-CoV-2 expression constructs also available
  See all of our COVID-19-related Expression Constructs
Catalog NumberProduct name
CVD19-140PA/VA-1ACE2 Expression Lentivector, pCDH-CMV-ACE2-EF1α-Puro (Plasmid or Pre-packaged Lentivirus)
CVD19-100PA/VA-1NRP1 Expression Lentivector, pCDH-CMV-NRP1-EF1α-Neo (Plasmid or Pre-packaged Lentivirus)
CVD19-120PA/VA-1SARS-CoV-2 Nucleocapsid (N protein) Expression Lentivector, pCDH-CMV-SARS-CoV-2-N-EF1α-Puro (Plasmid or Pre-packaged Lentivirus)
CVD19-130PA/VA-1SARS-CoV-2 Spike Glycoprotein (S) Expression Lentivector, pCDH-CMV-SARS-CoV-2-S-EF1α-Puro (Plasmid or Pre-packaged Lentivirus)
CVD19-135PA/VA-1SARS-CoV-2 Humanized Spike Glycoprotein (S) Expression Lentivector, pCDH-CMV-SARS-CoV-2-hS-EF1α-Puro (Plasmid or Pre-packaged Lentivirus)
CVD19-200A-1HEK293 ACE2 Stable Cell Line
CVD19-260A-1HEK293-ACE2-NRP1 Overexpression Stable Cell Line
CVD19-220A-1HEK293 "N" SARS-CoV-2 Nucleocapsid Overexpression Stable Cell Line
CVD19-420A-1
CVD19-425A-1
"N" SARS-CoV-2 Nucleocapsid mRNA
CVD19-430A-1
CVD19-435A-1
"S" SARS-CoV-2 Spike Glycoprotein mRNA
 

How It Works

Supporting Data

Citations